BEAM logo

Beam Therapeutics Inc. (BEAM) Selling, General & Administrative Expenses

Annual SG&A:

$0.00-$116.81M(-100.00%)
December 31, 2024

Summary

  • As of today, BEAM annual SG&A is $0.00, with the most recent change of -$116.81 million (-100.00%) on December 31, 2024.
  • During the last 3 years, BEAM annual SG&A has fallen by -$57.22 million (-100.00%).
  • BEAM annual SG&A is now -100.00% below its all-time high of $116.81 million, reached on December 31, 2023.

Performance

BEAM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

Quarterly SG&A:

$26.86M-$1.08M(-3.87%)
June 30, 2025

Summary

  • As of today, BEAM quarterly SG&A is $26.86 million, with the most recent change of -$1.08 million (-3.87%) on June 30, 2025.
  • Over the past year, BEAM quarterly SG&A has dropped by -$2.77 million (-9.34%).
  • BEAM quarterly SG&A is now -37.91% below its all-time high of $43.26 million, reached on December 31, 2023.

Performance

BEAM Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

TTM SG&A:

-$6.50B-$398.58M(-6.54%)
June 30, 2025

Summary

  • As of today, BEAM TTM SG&A is -$6.50 billion, with the most recent change of -$398.58 million (-6.54%) on June 30, 2025.
  • Over the past year, BEAM TTM SG&A has dropped by -$6.62 billion (-5296.89%).
  • BEAM TTM SG&A is now -5109.35% below its all-time high of -$124.72 million.

Performance

BEAM TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

BEAM Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-100.0%-9.3%-5296.9%
3Y3 Years-100.0%+11.6%-8553.6%
5Y5 Years-100.0%+287.2%-10000.0%

BEAM Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-100.0%at low-37.9%+23.1%-83.8%at low
5Y5-Year-100.0%at low-37.9%+258.0%-545.5%at low
All-TimeAll-Time-100.0%at low-37.9%+847.7%-5109.4%at low

BEAM Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$26.86M(-3.9%)
$109.97M(-2.5%)
Mar 2025
-
$27.94M(-2.5%)
$112.74M(+1.1%)
Dec 2024
$0.00(-100.0%)
$28.66M(+8.1%)
$111.53M(-11.6%)
Sep 2024
-
$26.52M(-10.5%)
$126.12M(+0.9%)
Jun 2024
-
$29.63M(+10.9%)
$125.02M(+4.1%)
Mar 2024
-
$26.72M(-38.2%)
$120.05M(+2.8%)
Dec 2023
$116.81M(+33.0%)
$43.26M(+70.2%)
$116.81M(+21.4%)
Sep 2023
-
$25.41M(+3.1%)
$96.24M(+3.9%)
Jun 2023
-
$24.66M(+5.0%)
$92.64M(+0.6%)
Mar 2023
-
$23.49M(+3.6%)
$92.05M(+4.8%)
Dec 2022
$87.81M(+53.4%)
$22.68M(+4.0%)
$87.81M(+5.9%)
Sep 2022
-
$21.82M(-9.3%)
$82.90M(+7.9%)
Jun 2022
-
$24.06M(+25.0%)
$76.86M(+16.1%)
Mar 2022
-
$19.25M(+8.3%)
$66.20M(+15.7%)
DateAnnualQuarterlyTTM
Dec 2021
$57.22M(+93.3%)
$17.77M(+12.7%)
$57.22M(+19.7%)
Sep 2021
-
$15.77M(+17.7%)
$47.80M(+20.9%)
Jun 2021
-
$13.40M(+30.5%)
$39.53M(+19.6%)
Mar 2021
-
$10.27M(+23.0%)
$33.07M(+11.7%)
Dec 2020
$29.61M(+44.0%)
$8.35M(+11.4%)
$29.61M(+8.0%)
Sep 2020
-
$7.50M(+8.1%)
$27.41M(+7.9%)
Jun 2020
-
$6.94M(+1.8%)
$25.40M(+8.4%)
Mar 2020
-
$6.81M(+10.6%)
$23.44M(+14.0%)
Dec 2019
$20.55M(+73.2%)
$6.16M(+12.3%)
$20.55M(+13.5%)
Sep 2019
-
$5.49M(+10.2%)
$18.10M(+17.2%)
Jun 2019
-
$4.98M(+26.7%)
$15.45M(+47.5%)
Mar 2019
-
$3.93M(+5.9%)
$10.47M(+60.0%)
Dec 2018
$11.87M(+487.2%)
$3.71M(+30.9%)
$6.54M(+130.9%)
Sep 2018
-
$2.83M
$2.83M
Dec 2017
$2.02M
-
-

FAQ

  • What is Beam Therapeutics Inc. annual SG&A?
  • What is the all-time high annual SG&A for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. annual SG&A year-on-year change?
  • What is Beam Therapeutics Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. quarterly SG&A year-on-year change?
  • What is Beam Therapeutics Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. TTM SG&A year-on-year change?

What is Beam Therapeutics Inc. annual SG&A?

The current annual SG&A of BEAM is $0.00

What is the all-time high annual SG&A for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high annual SG&A is $116.81M

What is Beam Therapeutics Inc. annual SG&A year-on-year change?

Over the past year, BEAM annual SG&A has changed by -$116.81M (-100.00%)

What is Beam Therapeutics Inc. quarterly SG&A?

The current quarterly SG&A of BEAM is $26.86M

What is the all-time high quarterly SG&A for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high quarterly SG&A is $43.26M

What is Beam Therapeutics Inc. quarterly SG&A year-on-year change?

Over the past year, BEAM quarterly SG&A has changed by -$2.77M (-9.34%)

What is Beam Therapeutics Inc. TTM SG&A?

The current TTM SG&A of BEAM is -$6.50B

What is the all-time high TTM SG&A for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high TTM SG&A is -$124.72M

What is Beam Therapeutics Inc. TTM SG&A year-on-year change?

Over the past year, BEAM TTM SG&A has changed by -$6.62B (-5296.89%)
On this page